Cargando…
Hypertrophic Pachymeningitis with Persistent Intrathecal Inflammation Secondary to Neurosarcoidosis Treated with Intraventricular Chemotherapy: A Case Report
Hypertrophic pachymeningitis (HP) is a rare immune-mediated disease characterized by thickening of the dura mater with consecutive cranial neuropathy. While HP is usually treated with systemic immunotherapies, response to therapy is variable and may be limited by insufficient drug concentrations in...
Autores principales: | de Almeida Marcelino, Ana Luísa, Streit, Simon, Homeyer, Marie Alice, Bauknecht, Hans-Christian, Radbruch, Helena, Ruprecht, Klemens, Prüss, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294282/ https://www.ncbi.nlm.nih.gov/pubmed/37384037 http://dx.doi.org/10.1159/000531229 |
Ejemplares similares
-
Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report
por: Balaban, Denis T., et al.
Publicado: (2023) -
Isolated Neurosarcoidosis Presenting as Chronic Progressive Pachymeningitis
por: Abata, Joshua, et al.
Publicado: (2023) -
A Rare Ocular Manifestation of Idiopathic Hypertrophic Cranial Pachymeningitis
por: Lee, Josephine En Hui, et al.
Publicado: (2021) -
Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study
por: Xiao, Xuewen, et al.
Publicado: (2020) -
Neurosarcoidosis Mimicking the Recurrence of Malignant Lymphoma
por: Murakami, Keishu, et al.
Publicado: (2021)